Type IV Hypersensitivity is a form of delayed-type hypersensitivity, an immune response that occurs several days after exposure to an antigen. It is mediated by T-cells and macrophages, which release cytokines and other inflammatory mediators. This type of hypersensitivity is associated with a variety of allergic and autoimmune diseases, including asthma, eczema, and rheumatoid arthritis. It is also involved in the rejection of transplanted organs.
The Type IV Hypersensitivity market is a subset of the Allergy and Immunology market, which is focused on the diagnosis, treatment, and prevention of allergic and immunological diseases. This market includes a variety of products and services, such as diagnostic tests, immunotherapy, and medications. It also includes research and development of new treatments and therapies.
Some companies in the Type IV Hypersensitivity market include Allergan, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
